7	93	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(0, 0), 'end':(0, 18), 'text':'Spontaneous germline point mutations in humans occur at average rates of 4-160 x 10 -9 per haploid genome ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(0, 19), 'end':(0, 34), 'text':'tend to be paternal in origin with a male and female mutation ratio of 2-7 ,'}, {'start':(0, 35), 'end':(0, 48), 'text':'and show only a modest effect of parental age on mutation rate - .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 10), 'text':'However a different pattern is evident in some congenital disorders ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 11), 'end':(1, 16), 'text':'which arise from specific point mutations'}, {'start':(1, 17), 'end':(1, 27), 'text':'that are 2-3 orders of magnitude more common than expected .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 9), 'text':'The causative mutations nearly always originate from the healthy fathers'}, {'start':(2, 10), 'end':(2, 17), 'text':'( male and female ratio > 10 )'}]}, {'start':(2, 18), 'end':(2, 31), 'text':'who , on average , are 2-6 years older than the population mean .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 11), 'text':'We term mutations with these collective properties paternal age effect mutations :'}, {'start':(3, 12), 'end':(3, 33), 'text':'the best documented examples occur in the genes FGFR2 , FGFR3 , HRAS , PTPN11 and RET ( online ) - .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(4, 0), 'end':(4, 7), 'text':'In all cases the mutations exhibit dominant inheritance'}, {'start':(4, 8), 'end':(4, 15), 'text':'and encode missense substitutions with gain-of-function properties .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 18), 'text':'The pathological basis of paternal age effect mutations needs to be explained in the context of normal spermatogenesis ,'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 19), 'end':(5, 25), 'text':'in which progeny of diploid stem cells'}, {'start':(5, 26), 'end':(5, 35), 'text':'( spermatogonia ) have a choice either to self-renew ,'}]}, {'start':(5, 36), 'end':(5, 47), 'text':'or to differentiate through a series of mitotic and meiotic divisions ,'}]}]}, {'start':(5, 48), 'end':(5, 52), 'text':'leading to mature sperm .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(6, 0), 'end':(6, 23), 'text':'Amongst paternal age effect mutations , the properties of the 755C > G transversion in FGFR2 ( a cause of Apert syndrome ) ,'}, {'start':(6, 24), 'end':(6, 30), 'text':'have been investigated in most detail .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'None', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(7, 0), 'end':(7, 3), 'text':'A quantitative assay showed'}, {'start':(7, 4), 'end':(7, 27), 'text':'that the mutation level is elevated ( 10 -6 -10 -4 ) in the sperm of many healthy men and increases with age .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 21), 'text':'However , the mutation levels are usually distributed very unequally between the two FGFR2 alleles , a pattern inconsistent with the notion'}, {'start':(8, 22), 'end':(8, 33), 'text':'that the mutations originate from many independent replication errors during spermatogenesis .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'cause', 'direction':'LeftToRight', 'children':[{'start':(9, 0), 'end':(9, 7), 'text':'Instead , rare initial mutations could become enriched'}, {'start':(9, 8), 'end':(9, 13), 'text':'because of a selective advantage :'}]}, {'start':(9, 14), 'end':(9, 36), 'text':'this would lead to progressive clonal expansion of the mutant spermatogonia and account for the allelic skewing and paternal age effect , .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'LeftToRight', 'children':[{'start':(10, 0), 'end':(10, 9), 'text':'Putative FGFR2-mutant clones have been observed in normal testes ,'}, {'start':(10, 10), 'end':(10, 12), 'text':'as predicted .'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 0), 'end':(11, 20), 'text':'Additional analyses of sperm and testes for a different Apert syndrome FGFR2 mutation , , as well as an FGFR3 mutation'}, {'start':(11, 21), 'end':(11, 25), 'text':'that causes achondroplasia - ,'}]}, {'start':(11, 26), 'end':(11, 38), 'text':'support a shared mechanism for the origin of paternal age effect disorders .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 0), 'end':(12, 15), 'text':'The proposed clonal expansions of spermatogonia are reminiscent of the action of oncogenes in neoplasia ;'}, {'start':(12, 16), 'end':(12, 35), 'text':'consistent with this , somatic FGFR2 mutations identical to those causing Apert syndrome are frequent in endometrial carcinoma , .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(13, 0), 'end':(13, 2), 'text':'We therefore proposed'}, {'start':(13, 3), 'end':(13, 16), 'text':'that the mutant clones in the testis might themselves progress to testicular tumors .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(14, 0), 'end':(14, 19), 'text':'Previous attempts to identify FGFR2 or FGFR3 mutations in common testicular germ cell tumors ( seminomas and non seminomas )'}, {'label':'joint', 'direction':'None', 'children':[{'start':(14, 20), 'end':(14, 24), 'text':'yielded negative results , ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(14, 25), 'end':(14, 37), 'text':'however these tumors occur predominantly in young men ( aged 25-35 years )'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 38), 'end':(14, 45), 'text':'and arise from a fetal precursor state ,'}, {'start':(14, 46), 'end':(14, 60), 'text':'which is difficult to reconcile with the proposed origin of paternal age effect mutations .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 0), 'end':(15, 21), 'text':'Here we have investigated spermatocytic seminomas , a rare type of testicular germ cell tumor with a later mean age of onset'}, {'start':(15, 22), 'end':(15, 27), 'text':'( ~ 54 years ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 0), 'end':(16, 9), 'text':'These tumors present as slow growing , well circumscribed swellings'}, {'label':'joint', 'direction':'None', 'children':[{'start':(16, 10), 'end':(16, 12), 'text':'that rarely metastasize'}, {'start':(16, 13), 'end':(16, 24), 'text':'and are thought to originate from the adult spermatogonial lineage , .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(17, 0), 'end':(17, 23), 'text':'We sequenced mutation hotspots in fibroblast growth factor receptor genes ( FGFR1 , FGFR2 , FGFR3 ) in 30 spermatocytic seminomas ( online )'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 24), 'end':(17, 33), 'text':'and found the identical 1948A > G transition in FGFR3'}, {'start':(17, 34), 'end':(17, 37), 'text':'( encoding K650E )'}]}, {'start':(17, 38), 'end':(17, 44), 'text':'in two different tumors ( ) .'}]}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 0), 'end':(18, 16), 'text':'In both cases , histopathologically normal testis adjacent to the tumor was negative for the mutation .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(19, 0), 'end':(19, 26), 'text':'This mutation has previously been identified in the germline heterozygous state in the neonatally lethal skeletal disorder thanatophoric dysplasia type II ( TDII , MIM187601 ) ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 27), 'end':(19, 42), 'text':'and as a somatic mutation in bladder tumors , , seborrheic keratoses , and multiple myeloma'}, {'start':(19, 43), 'end':(19, 46), 'text':'( online ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 0), 'end':(20, 7), 'text':'The FGFR3 K650E substitution is strongly activating ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 8), 'end':(20, 21), 'text':'allowing constitutive autophosphorylation of the intracellular tyrosine kinase domain in the absence of ligand'}, {'start':(20, 22), 'end':(20, 26), 'text':'( online ) , .'}]}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(21, 0), 'end':(21, 10), 'text':'A paternal age effect in thanatophoric dysplasia was described previously ,'}, {'start':(21, 11), 'end':(21, 18), 'text':'but genetic studies were not undertaken , .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 0), 'end':(22, 8), 'text':'Based on the birth prevalence of thanatophoric dysplasia ('}, {'start':(22, 9), 'end':(22, 26), 'text':'which is caused by several different FGFR3 mutations ) , of 2.4 x 10 -5 ( refs .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(23, 0), 'end':(23, 1), 'text':', )'}, {'start':(23, 2), 'end':(23, 32), 'text':'and by analogy with other FGFR2 and FGFR3 mutations - , we expected the 1948A > G mutation to be present at average levels of ~ 10 -5 in sperm .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(24, 0), 'end':(24, 9), 'text':'Since five other point mutations of the FGFR3 K650 codon'}, {'start':(24, 10), 'end':(24, 21), 'text':'( AAG ) have been described in germline congenital disorders , ,'}]}, {'start':(24, 22), 'end':(24, 35), 'text':'and three of these also as somatic mutations in tumors , , , ,'}]}, {'start':(24, 36), 'end':(24, 48), 'text':'we aimed to quantify all 9 possible substitutions at FGFR3 codon 650 .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 0), 'end':(25, 8), 'text':'We divided each DNA sample into 3 aliquots ,'}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(25, 9), 'end':(25, 29), 'text':'2 of which were spiked with different amounts of diluted genomic DNA heterozygous for the FGFR3 1948A > C substitution ,'}, {'start':(25, 30), 'end':(25, 41), 'text':'to provide an internal standard for absolute quantification of mutation levels .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(26, 0), 'end':(26, 10), 'text':'Samples were digested with BpiI ( recognition sequence GAAGAC ) ,'}, {'start':(26, 11), 'end':(26, 20), 'text':'to enrich equally for all FGFR3 K650 codon substitutions .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(27, 0), 'end':(27, 3), 'text':'During subsequent PCR amplification'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(27, 4), 'end':(27, 6), 'text':'we used primers'}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(27, 7), 'end':(27, 10), 'text':'containing unique 4-nucleotide tags'}, {'start':(27, 11), 'end':(27, 37), 'text':'to identify each sample , then all products for a given spike level were pooled to construct 3 independent libraries for massively parallel sequencing ( ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(28, 0), 'end':(28, 9), 'text':'To assess the accuracy and reproducibility of the assay ,'}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(28, 10), 'end':(28, 33), 'text':'we estimated mutation levels for two different FGFR3 K650 substitutions ( 1948A > G [ 2 samples ] and 1949A > T ) ,'}, {'start':(28, 34), 'end':(28, 41), 'text':'when progressively diluted with normal blood DNA .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(29, 0), 'end':(29, 5), 'text':'For both 1948A > G samples'}, {'start':(29, 6), 'end':(29, 33), 'text':'we found an excellent correspondence between the amount of input DNA and the estimated mutation level , at least down to an input concentration of 10 -5 ;'}]}, {'label':'contrast', 'direction':'None', 'children':[{'start':(29, 34), 'end':(29, 51), 'text':'for the 1949A > T sample , mutation levels were underestimated by a factor ~ 3.3 fold ,'}, {'start':(29, 52), 'end':(29, 65), 'text':'but were also strongly correlated with the amount of input DNA ( ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(30, 0), 'end':(30, 21), 'text':'We estimated levels of the 9 possible single nucleotide substitutions at the FGFR3 K650 codon in 78 sperm and 8 blood samples'}, {'start':(30, 22), 'end':(30, 26), 'text':'obtained from healthy donors .'}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(31, 0), 'end':(31, 13), 'text':'Whereas relatively low counts of all mutations were found in the blood samples ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(31, 14), 'end':(31, 35), 'text':'levels of the 1948A > G substitution were often much higher ( maximum of 2.1 x 10 -4 ) in sperm samples'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(31, 36), 'end':(31, 42), 'text':'and were significantly correlated with donor age'}, {'start':(31, 43), 'end':(31, 57), 'text':'( Spearman rank r s = 0.34 , P = 0.002 ) ( ) .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(32, 0), 'end':(32, 17), 'text':'1948A > G was the most prevalent substitution in 66 and 78 sperm donors ( ; online )'}, {'start':(32, 18), 'end':(32, 29), 'text':'and accounted for 73 % of total mutations in these samples .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(33, 0), 'end':(33, 31), 'text':'Amongst the other potential substitutions , 1949A > C ( K650T ) accounted for 17 % of total mutations in sperm was the most prevalent mutation in 8 and 78 samples .'}, {'start':(34, 0), 'end':(34, 31), 'text':'This change has been described as a constitutional mutation in a few individuals with acanthosis nigricans and mild short stature , and as a somatic mutation in bladder tumors ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(35, 0), 'end':(35, 3), 'text':'The three other substitutions'}, {'start':(35, 4), 'end':(35, 29), 'text':'that accounted for total mutation levels > 1 % , 1949A > T ( K650M ) and 1950G > C and T ( K650N ) ,'}]}, {'start':(35, 30), 'end':(35, 41), 'text':'have also been observed in constitutional disorders ( , ) , .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(36, 0), 'end':(36, 6), 'text':'By contrast , the three point mutations'}, {'start':(36, 7), 'end':(36, 17), 'text':'that encode silent , conservative or stop changes ( ) ,'}]}, {'start':(36, 18), 'end':(36, 29), 'text':'which have not been reported as either germline or somatic mutations ,'}]}, {'start':(36, 30), 'end':(36, 39), 'text':'were all > 1000-fold less prevalent than 1948A > G.'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(37, 0), 'end':(37, 28), 'text':'The marked variations in prevalence of different mutations at the K650 codon , and correspondence with the functional effect of the encoded substitution , suggest differential selection of cells'}, {'start':(37, 29), 'end':(37, 32), 'text':'expressing mutant proteins .'}]}]}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(38, 0), 'end':(38, 21), 'text':'We compared the average levels in sperm of the 9 FGFR3 K650 point mutations with four other measurements for this codon .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(39, 0), 'end':(39, 18), 'text':'There was a strong correlation ( r = 0.95 ) with total cases reported of each germline mutation ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(39, 19), 'end':(39, 19), 'text':'indicating'}, {'start':(39, 20), 'end':(39, 43), 'text':'that the level of mutations in sperm is likely to be the major determinant of the population prevalence of different pathogenic germline mutations .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(40, 0), 'end':(40, 14), 'text':'There was also a strong correlation ( r = 0.94 ) with the total cases'}, {'start':(40, 15), 'end':(40, 23), 'text':'reported of each somatic mutation in bladder tumors ,'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(40, 24), 'end':(40, 24), 'text':'indicating'}, {'start':(40, 25), 'end':(40, 40), 'text':'that similar mutation and selection forces are likely to act in these distinct biological contexts .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(41, 0), 'end':(41, 8), 'text':'The correlations were substantially weaker with the mutation distribution'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(41, 9), 'end':(41, 12), 'text':'observed in seborrheic keratoses'}, {'start':(41, 13), 'end':(41, 17), 'text':'( r = 0.33 )'}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(41, 18), 'end':(41, 26), 'text':'and with the relative activation potential of the TK'}, {'start':(41, 27), 'end':(41, 32), 'text':'measured by in vitro kinase assay'}]}, {'start':(41, 33), 'end':(41, 38), 'text':'( r = 0.27 ) :'}]}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(41, 39), 'end':(41, 42), 'text':'in both contexts ,'}, {'start':(41, 43), 'end':(41, 58), 'text':'the gain-of-function effect of the K650M mutation appears to surpass that of K650E ( ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(42, 0), 'end':(42, 12), 'text':'However , heterozygosity for K650M ( or the equivalent K644M in mouse )'}, {'start':(42, 13), 'end':(42, 22), 'text':'leads to a viable phenotype in both species , ,'}]}, {'start':(42, 23), 'end':(42, 33), 'text':'whereas K650E ( K644E in mouse ) is lethal , ,'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(42, 34), 'end':(42, 35), 'text':'which demonstrates'}, {'start':(42, 36), 'end':(42, 58), 'text':'that the in vitro kinase measurement does not capture all dimensions of the pathological consequences of these two substitutions ( see ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(43, 0), 'end':(43, 9), 'text':'We screened 14 additional genes in the spermatocytic seminomas ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(43, 10), 'end':(43, 31), 'text':'including genes ( i ) mutated in syndromes exhibiting a strong paternal age effect ( HRAS , PTPN11 , RET ) ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(43, 32), 'end':(43, 56), 'text':'( ii ) involved in signal transduction pathways ( mitogen activated protein kinase [ MAPK ] and phosphoinositide-3 kinase [ PI3K ] ) of proteins'}, {'start':(43, 57), 'end':(43, 129), 'text':'encoded by class ( i ) genes and for which pathogenic activating mutations have been reported ( AKT1 , BRAF , KRAS , MAP2K1 , MAP2K2 , NRAS , PIK3CA , SOS1 ) and ( iii ) genes for which oncogenic mutations are commonly found in tumors ( bladder , thyroid , and endometrial cancers ) where paternal age effect mutations have also been described ( CTNNB1 , EGFR , KIT ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(44, 0), 'end':(44, 11), 'text':'Five mutations ( all in tumors negative for FGFR3 mutations ) ,'}, {'start':(44, 12), 'end':(44, 24), 'text':'were found in HRAS at the Q61 codon hotspot of activating mutations :'}]}, {'start':(44, 25), 'end':(44, 44), 'text':'3 were 182A > G ( Q61R ) transitions and 2 were 181C > A ( Q61K ) transversions .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(45, 0), 'end':(45, 5), 'text':'All mutations were apparently homozygous ,'}, {'start':(45, 6), 'end':(45, 20), 'text':'and were absent in adjacent normal tissue in the four available cases ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(46, 0), 'end':(46, 16), 'text':'Q61R and Q61K substitutions are common in human cancers ( Catalogue of Somatic Mutations in Cancer :'}, {'label':'joint', 'direction':'None', 'children':[{'start':(46, 17), 'end':(46, 18), 'text':'http://www.sanger.ac.uk/perl/genetics/CGP/cosmic )'}, {'start':(46, 19), 'end':(46, 28), 'text':'and are both highly activating in a transformation assay .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'None', 'children':[{'start':(47, 0), 'end':(47, 15), 'text':'In the germline , heterozygous HRAS mutations cause Costello syndrome ( MIM218040 ) , , ,'}, {'start':(47, 16), 'end':(47, 24), 'text':'but no substitution at Q61 has been identified ,'}]}, {'start':(47, 25), 'end':(47, 33), 'text':'which likely reflects lethality of these mutations , ,'}]}, {'start':(47, 34), 'end':(47, 37), 'text':'( see ) .'}]}, {'start':(48, 0), 'end':(48, 12), 'text':'No mutations were identified in the other 13 genes screened ( ) .'}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(49, 0), 'end':(49, 33), 'text':'The average age of patients positive for FGFR3 or HRAS mutations ( 74.9 years ) was significantly greater than for mutation negative cases ( 57.6 years ) ( Student t-test P = 0.0009 )'}, {'start':(49, 34), 'end':(49, 36), 'text':'( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(50, 0), 'end':(50, 12), 'text':'To evaluate further the role of FGFR3 and HRAS in spermatocytic seminomas ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(50, 13), 'end':(50, 20), 'text':'we examined protein distribution in 26 tumors ,'}, {'start':(50, 21), 'end':(50, 27), 'text':'including all 7 mutation positive cases .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(51, 0), 'end':(51, 4), 'text':'FGFR3 ( ref . )'}, {'label':'joint', 'direction':'None', 'children':[{'start':(52, 0), 'end':(52, 15), 'text':'and HRAS are expressed in subpopulations of cells in normal seminiferous tubules ( insets ) ;'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(52, 16), 'end':(52, 48), 'text':'pERK1 and 2 , an activated effector of the MAPK pathway ( ) , is present in the nucleus of a subset of spermatogonia , primary spermatocytes and a subset of round spermatids'}, {'start':(52, 49), 'end':(52, 53), 'text':'( not shown ) .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(53, 0), 'end':(53, 20), 'text':'In spermatocytic seminomas , we found strong positive staining for FGFR3 in 5 and 24 tumors ( including 1 and 2'}, {'start':(53, 21), 'end':(53, 26), 'text':'that were FGFR3 mutation positive )'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(53, 27), 'end':(53, 39), 'text':'and for HRAS in 15 and 26 tumors ( including 4 and 5'}, {'start':(53, 40), 'end':(53, 48), 'text':'that were HRAS mutation positive ) ( ) ;'}]}]}, {'start':(53, 49), 'end':(53, 66), 'text':'18 and 26 ( 70 % ) of tumors were strongly positive for one or both proteins .'}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(54, 0), 'end':(54, 8), 'text':'In most tumors ( 18 and 24 ) ,'}, {'start':(54, 9), 'end':(54, 15), 'text':'including 6 and 7 mutated cases ,'}]}, {'start':(54, 16), 'end':(54, 25), 'text':'the presence of FGFR3 and HRAS was mutually exclusive ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(54, 26), 'end':(54, 36), 'text':'but this did not show a simple correlation with the gene'}, {'start':(54, 37), 'end':(54, 45), 'text':'mutated in the mutation positive cases ( ) .'}]}]}]}]}, {'start':(55, 0), 'end':(55, 17), 'text':'pERK1 and 2 was detected in 14 and 25 ( 56 % ) of tumors ( ) .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(56, 0), 'end':(56, 4), 'text':'Our results support the proposal'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(56, 5), 'end':(56, 7), 'text':'that clonal expansion'}, {'start':(56, 8), 'end':(56, 22), 'text':'resulting from selective advantage of paternal age effect mutations can lead to testicular tumors .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(57, 0), 'end':(57, 23), 'text':'To our knowledge this work links for the first time in any organism the processes of mutation in the soma ( causing neoplasia )'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(57, 24), 'end':(57, 25), 'text':'and germline'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(57, 26), 'end':(57, 35), 'text':'( causing heritable disorders in the next generation ) ,'}, {'start':(57, 36), 'end':(57, 53), 'text':'which normally occur in different cells , to a mutational event likely occurring in the same cell .'}]}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(58, 0), 'end':(58, 15), 'text':'The clonal expansions presumably involve altered dynamics of stem cell self-renewal , through a proliferative advantage'}, {'start':(58, 16), 'end':(58, 22), 'text':'( possibly enhanced by preferential survival )'}]}, {'start':(58, 23), 'end':(58, 29), 'text':'compared to neighboring non mutant cells ,'}]}, {'start':(58, 30), 'end':(58, 38), 'text':'analogous to the role of oncogenes in cancer .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(59, 0), 'end':(59, 33), 'text':'Only weak advantage ( selection coefficient of 0.002-0 .01 per cell generation ) , , is necessary to account for the observed mutation levels in sperm and paternal age excess ( 2-6 years )'}, {'start':(59, 34), 'end':(59, 40), 'text':'observed for the associated germline disorders .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(60, 0), 'end':(60, 10), 'text':'Our data favour a premeiotic origin , for spermatocytic seminoma ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(60, 11), 'end':(60, 16), 'text':'which is supported by the observation'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(60, 17), 'end':(60, 26), 'text':'that transfection of murine spermatogonial stem cells with mutant HRAS'}, {'start':(60, 27), 'end':(60, 30), 'text':'( encoding G12V )'}]}, {'start':(60, 31), 'end':(60, 34), 'text':'causes seminomatous tumors .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(61, 0), 'end':(61, 2), 'text':'Men originating tumors'}, {'start':(61, 3), 'end':(61, 12), 'text':'containing FGFR3 and HRAS mutations were significantly older than those'}]}, {'start':(61, 13), 'end':(61, 17), 'text':'without mutations ( ) ,'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(61, 18), 'end':(61, 18), 'text':'suggesting'}, {'start':(61, 19), 'end':(61, 28), 'text':'that the mutated tumors represent a distinct pathological subset .'}]}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(62, 0), 'end':(62, 7), 'text':'Based on these and previous data - ,'}, {'start':(62, 8), 'end':(62, 22), 'text':'activating mutations in FGFR2 , FGFR3 and HRAS promote clonal expansion in the testis .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'start':(63, 0), 'end':(63, 6), 'text':'The encoded proteins are physiologically connected ,'}, {'start':(63, 7), 'end':(63, 23), 'text':'as HRAS lies downstream of FGFRs in the growth factor receptor signaling pathway ( ) , .'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(64, 0), 'end':(64, 4), 'text':'By considering the additional genes'}, {'start':(64, 5), 'end':(64, 18), 'text':'( RET , PTPN11 ) subject to paternal age effect mutations ( ) ,'}]}, {'start':(64, 19), 'end':(64, 24), 'text':'these connections can be extended .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(65, 0), 'end':(65, 11), 'text':'Hence , RET is , like FGFRs , a receptor tyrosine kinase'}, {'start':(65, 12), 'end':(65, 14), 'text':'( RTK )'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(65, 15), 'end':(65, 18), 'text':'that signals through RAS'}, {'start':(65, 19), 'end':(65, 27), 'text':'and plays a critical role in spermatogonial renewal .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(66, 0), 'end':(66, 20), 'text':'Overexpression of GDNF , the RET ligand , leads to accumulation of undifferentiated spermatogonia and testicular tumors in older mice .'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(67, 0), 'end':(67, 4), 'text':'PTPN11 ( encoding SHP2 )'}, {'start':(67, 5), 'end':(67, 11), 'text':'positively regulates RTK-RAS signaling ( ) .'}]}]}]}]}, {'start':(68, 0), 'end':(68, 21), 'text':'A central role for abnormal FGFR3-RAS signaling in the origin of spermatocytic seminoma is supported by the immunohistochemical analysis ( ) .'}]}]}, {'label':'contrast', 'direction':'None', 'children':[{'start':(69, 0), 'end':(69, 9), 'text':'Both FGFR3 and RAS are present in normal testis ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(69, 10), 'end':(69, 17), 'text':'but are markedly elevated in spermatocytic seminomas ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(69, 18), 'end':(69, 19), 'text':'including cases'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(69, 20), 'end':(69, 24), 'text':'lacking FGFR3 and HRAS mutations'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(69, 25), 'end':(69, 25), 'text':'('}, {'start':(69, 26), 'end':(69, 39), 'text':'in which other mechanisms are presumably leading to upregulation of the proteins ) .'}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(70, 0), 'end':(70, 12), 'text':'The reciprocal pattern of increased FGFR3 or HRAS staining in many tumors suggests'}, {'start':(70, 13), 'end':(70, 23), 'text':'that elevation of either component is sufficient for pathway activation .'}]}, {'label':'evaluation', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(71, 0), 'end':(71, 10), 'text':'Similar observations have been made in low grade bladder cancer ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(71, 11), 'end':(71, 21), 'text':'in which mutations in FGFR3 and RAS genes are mutually exclusive'}, {'start':(71, 22), 'end':(71, 33), 'text':'and FGFR3 mutation status and protein expression do not always correlate .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(72, 0), 'end':(72, 20), 'text':'The spectrum of FGFR3 K650 codon mutations in sperm is very similar to that present in bladder cancer ( ) ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(72, 21), 'end':(72, 21), 'text':'suggesting'}, {'start':(72, 22), 'end':(72, 32), 'text':'that similar mutation-selection mechanisms operate in these distinct cellular contexts .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(73, 0), 'end':(73, 3), 'text':'RAS activates multiple pathways'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(73, 4), 'end':(73, 5), 'text':'including those'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(73, 6), 'end':(73, 9), 'text':'typically involved in proliferation'}, {'start':(73, 10), 'end':(73, 18), 'text':'( MAPK ) and survival ( PI3K ) .'}]}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(74, 0), 'end':(74, 3), 'text':'Activating mutations of genes'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(74, 4), 'end':(74, 10), 'text':'encoding downstream components of the MAPK pathway'}, {'start':(74, 11), 'end':(74, 20), 'text':'( BRAF , RAF1 , MEK1 and MEK2 ) ,'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(74, 21), 'end':(74, 23), 'text':'cause neuro-cardio-facial-cutaneous syndromes'}, {'start':(74, 24), 'end':(74, 53), 'text':'that overlap with PTPN11 and HRAS mutations ( ) , ; inhibition of the MAPK pathway in mice modeling specific Fgfr2 and Ptpn11 mutations ameliorates their abnormal phenotypes , .'}]}]}]}, {'label':'background', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(75, 0), 'end':(75, 12), 'text':'We observed pERK1 and 2 staining in 56 % of spermatocytic seminomas ,'}, {'start':(75, 13), 'end':(75, 22), 'text':'indicating pathological activation of the MAPK pathway ( ) .'}]}, {'start':(76, 0), 'end':(76, 12), 'text':'However the PI3K pathway has also been functionally implicated in spermatogonial self-renewal .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(77, 0), 'end':(77, 9), 'text':'We envisage a range of consequences for these selfish mutations'}, {'start':(77, 10), 'end':(77, 16), 'text':'occurring in spermatogonial cells ( ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'start':(78, 0), 'end':(78, 22), 'text':'Heterozygosity for the most highly activating mutations , such as FGFR3 K650E and HRAS Q61R and K , causes severe , lethal phenotypes'}, {'start':(78, 23), 'end':(78, 29), 'text':'when transmitted in the germline , .'}]}, {'start':(79, 0), 'end':(79, 21), 'text':'Additional secondary genetic changes at these loci ( ) would lead , in combination with other mutations , to spermatocytic seminoma .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(80, 0), 'end':(80, 40), 'text':'Moderately activating mutations , for example those encoding substitutions at G12 and G13 in HRAS ( Costello syndrome ) , , , in FGFR2 ( Apert syndrome ) ,- and FGFR3 ( achondroplasia ) , , , lead to clonal expansion'}, {'label':'temporal', 'direction':'LeftToRight', 'children':[{'start':(80, 41), 'end':(80, 49), 'text':'that is eventually limited by growth arrest or senescence'}, {'start':(80, 50), 'end':(80, 55), 'text':'before overt tumors become apparent .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'start':(81, 0), 'end':(81, 3), 'text':'We view this process'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(81, 4), 'end':(81, 11), 'text':'as analogous to that occurring in skin ,'}, {'start':(81, 12), 'end':(81, 25), 'text':'where a spectrum of activating FGFR3 mutations in keratinocytes leads to seborrheic keratoses .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(82, 0), 'end':(82, 3), 'text':'Diverse mutations in spermatogonia'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(82, 4), 'end':(82, 15), 'text':'that confer weaker selective advantage may lead to lower levels of enrichment'}, {'start':(82, 16), 'end':(82, 23), 'text':'( > 1-50 fold ) in sperm .'}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(83, 0), 'end':(83, 6), 'text':'As well as encoding missense substitutions ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(83, 7), 'end':(83, 13), 'text':'mutations could confer altered gene expression ,'}, {'start':(83, 14), 'end':(83, 25), 'text':'which shows a high fraction of positively selected changes in testis .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(84, 0), 'end':(84, 9), 'text':'Such subtle effects would be technically challenging to detect ,'}, {'start':(84, 10), 'end':(84, 27), 'text':'yet could contribute substantially to the burden of human disease , through a common disease-rare variant mechanism .'}]}, {'label':'cause', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(85, 0), 'end':(85, 2), 'text':'Cancer predisposing mutations'}, {'start':(85, 3), 'end':(85, 12), 'text':'are especially likely to be favored by this process ,'}]}, {'start':(85, 13), 'end':(85, 22), 'text':'posing an increased risk to offspring of older fathers .'}]}]}]}]}
93	98	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(0, 0), 'end':(0, 0), 'text':'METHODS'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 16), 'text':'Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/ .'}, {'label':'textual-organization', 'direction':'None', 'children':[{'start':(2, 0), 'end':(2, 1), 'text':'Accession codes'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 1), 'text':'GenBank :'}, {'start':(3, 2), 'end':(3, 19), 'text':'FGFR3 genomic DNA , NT_006081 ; FGFR3 exon IIIc cDNA , NM_000142 ; HRAS cDNA , NM_005343 .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 17), 'text':'cDNA numbering is given relative to the A ( = 1 ) of the ATG initiation codon ;'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(4, 18), 'end':(4, 18), 'text':'note'}, {'start':(4, 19), 'end':(4, 33), 'text':'that the FGFR3 K650 codon is alternatively numbered K652 in the exon IIIb spliceform .'}]}]}]}
0	1	{'start':(0, 0), 'end':(0, 16), 'text':'Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors'}
175	176	{'start':(0, 0), 'end':(0, 0), 'text':'3'}
172	173	{'start':(0, 0), 'end':(0, 1), 'text':'Supplementary Material'}
1	7	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 0), 'text':'Genes'}, {'start':(0, 1), 'end':(0, 12), 'text':'mutated in congenital malformation syndromes are frequently implicated in oncogenesis , ,'}]}, {'start':(0, 13), 'end':(0, 32), 'text':'but the causative germline and somatic mutations occur in separate cells at different times of an organism \'s life .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 6), 'text':'Here we unify these processes for mutations'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 7), 'end':(1, 11), 'text':'arising in male germ cells'}, {'start':(1, 12), 'end':(1, 18), 'text':'that show a paternal age effect .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 24), 'text':'Screening of 30 spermatocytic seminomas , for oncogenic mutations in 17 genes identified 2 mutations in FGFR3 ( both 1948A > G encoding K650E ,'}, {'start':(2, 25), 'end':(2, 32), 'text':'which causes thanatophoric dysplasia in the germline )'}]}, {'start':(2, 33), 'end':(2, 38), 'text':'and 5 mutations in HRAS .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(3, 0), 'end':(3, 6), 'text':'Massively parallel sequencing of sperm DNA showed'}, {'start':(3, 7), 'end':(3, 31), 'text':'that the FGFR3 mutation increases with paternal age , with a similar mutation spectrum at the K650 codon to that in bladder cancer , .'}]}, {'start':(4, 0), 'end':(4, 12), 'text':'Most spermatocytic seminomas show increased immunoreactivity for FGFR3 and and or HRAS .'}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(5, 0), 'end':(5, 1), 'text':'We propose'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 2), 'end':(5, 13), 'text':'that paternal age effect mutations activate a common " selfish " pathway'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 14), 'end':(5, 19), 'text':'supporting proliferation in the testis ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 20), 'end':(5, 27), 'text':'leading to diverse phenotypes in the next generation'}, {'start':(5, 28), 'end':(5, 36), 'text':'including fetal lethality , congenital syndromes and cancer .'}]}]}]}]}]}
98	172	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 1), 'text':'ONLINE METHODS'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 1), 'text':'Ethical approval'}, {'start':(2, 0), 'end':(2, 34), 'text':'Approval for the study was provided by the Oxfordshire Research Ethics Committee C ( OxREC C03 .076 ) and the Joint Research Ethics Committees of the Copenhagen and Frederiksberg Communes ( KF 01 265848 ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 1), 'text':'Biological samples'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 4), 'text':'We obtained 43 spermatocytic seminomas'}, {'start':(4, 5), 'end':(4, 19), 'text':'collected from tissue archives at hospitals in Denmark , Sweden and Oxford , UK ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 20), 'end':(4, 28), 'text':'and included mutation and immunohistochemistry data on 30 samples'}, {'start':(4, 29), 'end':(4, 48), 'text':'for which > 30 % ( average 64 % ; range 30 % -98 % ) of exons amplified .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 19), 'text':'The mean age of patients at the time of tumor removal was 61.9 years ( range 33-87 years ) .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(6, 0), 'end':(6, 7), 'text':'In addition to having typical morphological features ,'}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(6, 8), 'end':(6, 12), 'text':'the tumor type was confirmed'}, {'label':'contrast', 'direction':'None', 'children':[{'start':(6, 13), 'end':(6, 17), 'text':'by staining with MAGE-A4 ,'}, {'start':(6, 18), 'end':(6, 27), 'text':'while PLAP and OCT3 and 4 were negative , .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 6), 'text':'None of the tumors was invasive .'}, {'start':(8, 0), 'end':(8, 23), 'text':'Single ejaculates from 78 men ( aged 22.1-73 .9 years ) and 8 blood samples from individuals aged 36.6-73 years were donated anonymously .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(9, 0), 'end':(9, 43), 'text':'DNA samples from 2 patients heterozygous for FGFR3 1948A > G ( TD3 and TD6 ) , one patient heterozygous for 1949A > T ( SAD4 ) and one patient heterozygous for 1948A > C ( HCH1-spike , used as the spike DNA )'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 44), 'end':(9, 50), 'text':'were a kind gift from L. Legeai-Mallet'}, {'start':(9, 51), 'end':(9, 60), 'text':'( Hopital Necker-Enfants Malades , Paris , France ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 0), 'end':(10, 6), 'text':'Analysis of oncogenic mutations in spermatocytic seminomas'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 0), 'end':(11, 24), 'text':'DNA was extracted from paraffin embedded samples as described and mutation hotspots were analyzed by PCR amplification and DNA sequencing of the following genes :'}, {'start':(11, 25), 'end':(11, 58), 'text':'AKT1 , BRAF , CTNNB1 , EGFR , FGFR1 , FGFR2 , FGFR3 , HRAS , KIT , KRAS , MAP2K1 , MAP2K2 , NRAS , PIK3CA , PTPN11 , RET and SOS1 .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 0), 'end':(12, 26), 'text':'All PCRs were set up in a sterile UV-hood in a 30 mul reaction volume using 1x FastStart Buffer , 150 muM dNTPs , 0.16 muM primers'}, {'start':(12, 27), 'end':(12, 50), 'text':'( forward and reverse ) , 0.5 U FastStart Taq DNA polymerase and 0.05 U Pwo DNA polymerase ( both from Roche ) .'}]}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(13, 0), 'end':(13, 6), 'text':'When available , restriction digests were used'}, {'start':(13, 7), 'end':(13, 14), 'text':'to screen for the mutations of interest .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 0), 'end':(14, 15), 'text':'The PCR primers , conditions and genotyping methods are given in and the results in .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 0), 'end':(15, 13), 'text':'The products were cleaned ( 30 min at 37 degreesC in 0.2 x Exo'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(15, 14), 'end':(15, 19), 'text':'I buffer , 10 U Exonuclease'}, {'label':'joint', 'direction':'None', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 20), 'end':(15, 39), 'text':'I [ New England Biolabs ] and 2 U Shrimp Alkaline Phosphatase [ SAP , United States Biochemical ] ,'}, {'start':(15, 40), 'end':(15, 48), 'text':'followed by 15 min at 85 degreesC ) ,'}]}, {'start':(15, 49), 'end':(15, 53), 'text':'sequenced in both orientations ,'}]}, {'start':(15, 54), 'end':(15, 66), 'text':'and run on a ABI 3700 DNA sequencer ( Applied Biosystems ) .'}]}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(16, 0), 'end':(16, 0), 'text':'Positions'}, {'label':'joint', 'direction':'None', 'children':[{'start':(16, 1), 'end':(16, 16), 'text':'where germline and and or somatic mutations have been previously reported were specifically interrogated on chromatograms'}, {'start':(16, 17), 'end':(16, 20), 'text':'and scored independently .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(17, 0), 'end':(17, 9), 'text':'To evaluate the zygosity status of the tumor samples ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 10), 'end':(17, 15), 'text':'we genotyped 4 single nucleotide polymorphisms'}, {'start':(17, 16), 'end':(17, 28), 'text':'( SNPs ) ( rs2071616 , rs2659871 , rs41279090 and rs2075526 ) .'}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(18, 0), 'end':(18, 0), 'text':'Immunohistochemistry'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 0), 'end':(19, 39), 'text':'Representative cores ( 2 mm ) of tumor and adjacent normal tissue ( when available ) were punched from paraffin embedded blocks of spermatocytic seminomas and control tissues ( epididymis , prostate , classical seminoma and embryonal carcinoma ) .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 0), 'end':(20, 2), 'text':'Two tissue microarrays'}, {'label':'joint', 'direction':'None', 'children':[{'start':(20, 3), 'end':(20, 8), 'text':'containing 40 cores each were constructed'}, {'start':(20, 9), 'end':(20, 14), 'text':'and sectioned at 4 mum .'}]}]}]}]}]}]}]}, {'start':(21, 0), 'end':(21, 8), 'text':'Larger sections from some tumors were individually stained .'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(22, 0), 'end':(22, 23), 'text':'Immunohistochemical staining was performed using diluted monoclonal mouse antibodies to FGFR3 ( B-9 , 1:50 ) , HRAS ( F-235 , 1:80 ) ,'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 24), 'end':(22, 31), 'text':'OCT-3 / 4 ( C-10 , 1:250 )'}, {'start':(22, 32), 'end':(22, 82), 'text':'( all from Santa Cruz Biotechnology ) , MAGE-A4 ( 1:2000 ; a kind gift from Dr. G. Spagnoli , Basel , Switzerland ) and PLAP ( 1:50 ; DAKO ) , and a monoclonal rabbit antibody to pERK1 and 2 ( 20G11 , 1:150 ; Cell Signalling Technology ) ,'}]}, {'start':(22, 83), 'end':(22, 91), 'text':'by means of a standard indirect peroxidase method .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(23, 0), 'end':(23, 6), 'text':'Deparaffinized and rehydrated sections were microwaved ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(23, 7), 'end':(23, 37), 'text':'incubated first in 0.5 % H 2 O 2 , then in goat serum ( Histostain kit , Zymed ) before the addition of the primary antibodies overnight at 4degreesC ,'}, {'start':(23, 38), 'end':(23, 51), 'text':'while control sections of each specimen were incubated in the dilution buffer alone .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(24, 0), 'end':(24, 9), 'text':'After washing in Tris buffer and incubation with a peroxidase'}, {'start':(24, 10), 'end':(24, 19), 'text':'conjugated anti-mouse antibody ( or anti-rabbit for pERK ) ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(24, 20), 'end':(24, 29), 'text':'the reaction was developed in the presence of 3-amino-9-ethyl carbazole'}, {'start':(24, 30), 'end':(24, 42), 'text':'( AEC ) and H 2 O 2 ( Histostain kit ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 0), 'end':(25, 8), 'text':'All sections were counterstained with Mayer \'s haematoxylin .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(26, 0), 'end':(26, 7), 'text':'The sections were evaluated by two independent observers'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(26, 8), 'end':(26, 17), 'text':'and semi-quantitative scoring was used to assess the relative abundance'}, {'start':(26, 18), 'end':(26, 21), 'text':'of stained cells .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(27, 0), 'end':(27, 11), 'text':'Quantification of FGFR3 K650 codon mutation levels in sperm and blood samples'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'manner-means', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(28, 0), 'end':(28, 4), 'text':'DNA was extracted from blood'}, {'start':(28, 5), 'end':(28, 28), 'text':'and whole ejaculates as described and concentrations were precisely estimated at 3 dilutions against a dilution series of human genomic DNA ( Roche )'}]}, {'start':(28, 29), 'end':(28, 36), 'text':'using the TaqMan PCR conditions ( ) ,'}]}, {'start':(28, 37), 'end':(28, 55), 'text':'designed to a unique 91 bp amplicon located on chromosome 16 ( courtesy of M. de Gobbi ) .'}]}]}]}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(29, 0), 'end':(29, 13), 'text':'Measurements of mutation levels around the FGFR3 K650 codon ( cDNA position 1948-1950 )'}, {'start':(29, 14), 'end':(29, 23), 'text':'were performed using a strategy similar to that described .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(30, 0), 'end':(30, 55), 'text':'Triplicate samples each containing 10 mug of genomic DNA and either 2 ng ( spike level 10 -4 ) , 0.2 ng ( spike level 10 -5 ) or 0 ng ( unspiked ) of the HCH1-spike DNA were digested with 120 U XbaI and 40 U BpiI ( both Fermentas ) for 4 h .'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(31, 0), 'end':(31, 4), 'text':'The digested DNA samples ,'}, {'start':(31, 5), 'end':(31, 18), 'text':'flanked by 2 lanes of Lambda DNA and Eco91I marker ( Fermentas ) ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(31, 19), 'end':(31, 30), 'text':'were electrophoresed in a 0.9 % Tris-borate-EDTA ( TBE ) agarose gel'}, {'start':(31, 31), 'end':(31, 36), 'text':'( without ethidium bromide ) .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(32, 0), 'end':(32, 14), 'text':'This double digestion generates a 4,453 bp XbaI fragment carrying mutant FGFR3 K650 sequences ,'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(32, 15), 'end':(32, 32), 'text':'while the normal BpiI digested K650 sequence yields 2 fragments of 2,446 bp and 2,007 bp ( note'}, {'start':(32, 33), 'end':(32, 58), 'text':'that the FGFR3 genomic reference sequence contains a rare G allele at a known A and G SNP rs7688609 , located at cDNA position 1953 ;'}]}, {'start':(32, 59), 'end':(32, 68), 'text':'this nucleotide is shown as A in and ) .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(33, 0), 'end':(33, 8), 'text':'To select for mutant sequences , a gel slice'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(33, 9), 'end':(33, 13), 'text':'corresponding to 4.2-4 .6 kb'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(33, 14), 'end':(33, 24), 'text':'( the marker lanes were cut out of the gel ,'}, {'start':(33, 25), 'end':(33, 52), 'text':'stained with ethidium bromide and the 4,325 bp and 4,822 bp fragments were labelled with dye before being replaced in their original position in the gel ) ,'}]}]}]}, {'start':(33, 53), 'end':(33, 54), 'text':'was excised'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(33, 55), 'end':(33, 62), 'text':'and gel purified with an E.Z.N.A. MicroElute kit'}, {'start':(33, 63), 'end':(33, 67), 'text':'( Omega Bio-Tek ) .'}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(34, 0), 'end':(34, 7), 'text':'PCR amplification was performed ( PCR1 , )'}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(34, 8), 'end':(34, 25), 'text':'followed by a second round of selection with 30 U BpiI for 4 h in 100 mul volume'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(34, 26), 'end':(34, 29), 'text':'to yield selected material'}, {'start':(34, 30), 'end':(34, 36), 'text':'referred to as \' Pool2 \' .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(35, 0), 'end':(35, 21), 'text':'For each biological sample , an aliquot of 5 mul of the Pool2 material was used as template for a nested amplification'}, {'start':(35, 22), 'end':(35, 24), 'text':'( PCR2 )'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(35, 25), 'end':(35, 31), 'text':'in order to prepare the Illumina libraries'}, {'start':(35, 32), 'end':(35, 36), 'text':'( see below ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(36, 0), 'end':(36, 2), 'text':'Reconstruction dilution experiment'}, {'label':'joint', 'direction':'None', 'children':[{'start':(37, 0), 'end':(37, 12), 'text':'Genomic samples heterozygous for FGFR3 1948A > G ( TD3 and TD6 )'}, {'label':'joint', 'direction':'None', 'children':[{'start':(37, 13), 'end':(37, 96), 'text':'and 1949A > T ( SAD4 ) mutations were used in reconstruction experiments in which 10 mug of blood genomic DNA was mixed with a diluted series of mutant DNA corresponding to final mutation concentrations of 0 ( no added mutant DNA ) , 3 x 10 -6 ( 0.06 ng ) , 10 -5 ( 0.2 ng ) , 3 x 10 -5 ( 0.6 ng ) , 10 -4 ( 2 ng ) and 3 x 10 -4 ( 6 ng )'}, {'start':(37, 97), 'end':(37, 124), 'text':'and taken through the same protocol as the sperm and blood samples ( i.e. each dilution sample was mixed with 3 dilutions of the HCH1-spike DNA ) .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(38, 0), 'end':(38, 12), 'text':'The dilution samples were analyzed together with the blood and sperm samples .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(39, 0), 'end':(39, 1), 'text':'Control DNAs'}, {'start':(40, 0), 'end':(40, 24), 'text':'Mutant genomic samples TD3 , TD6 and SAD4 and 4 normal ( wild-type ) genomic DNA samples were included as controls in the analysis .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(41, 0), 'end':(41, 30), 'text':'These samples were taken through the same protocol of amplification with the exception of the omission of the BpiI enzyme from all the incubation steps , hence there was no selection'}, {'start':(41, 31), 'end':(41, 35), 'text':'imposed on these samples .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(42, 0), 'end':(42, 8), 'text':'Preparation of the Illumina libraries for massively parallel sequencing'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(43, 0), 'end':(43, 8), 'text':'Three independent libraries were prepared for massively parallel sequencing'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(43, 9), 'end':(43, 20), 'text':'using a modified version of the Illumina protocol " Digital Gene Expression-Tag'}, {'start':(43, 21), 'end':(43, 25), 'text':'Profiling with DpnII " .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(44, 0), 'end':(44, 8), 'text':'Each library contained a mixture of 112 DNA species'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(44, 9), 'end':(44, 19), 'text':'and was characterized by a specific amount of the HCH1-spike DNA'}, {'label':'joint', 'direction':'None', 'children':[{'start':(44, 20), 'end':(44, 25), 'text':'( library 1 was unspiked ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(44, 26), 'end':(44, 33), 'text':'library 2 contained the spike at 10 -5'}, {'start':(44, 34), 'end':(44, 44), 'text':'and library 3 contained the spike at 10 -4 ) .'}]}]}]}]}]}]}]}]}]}, {'start':(45, 0), 'end':(45, 8), 'text':'Primer sequences and reaction conditions are provided in .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(46, 0), 'end':(46, 10), 'text':'Five microlitres of each Pool2 sample was used for PCR amplification'}, {'start':(46, 11), 'end':(46, 13), 'text':'( PCR2 )'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(46, 14), 'end':(46, 19), 'text':'using 112 different forward 4nt-tag-Fw primers'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(46, 20), 'end':(46, 25), 'text':'( containing a common FGFR3 sequence'}, {'start':(46, 26), 'end':(46, 40), 'text':'preceded by a unique 4 nt tag and a DpnII cloning site ; ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(47, 0), 'end':(47, 5), 'text':'The tag primers were synthesized ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(47, 6), 'end':(47, 15), 'text':'HPLC purified and checked for synthesis error by mass spectroscopy'}, {'start':(47, 16), 'end':(47, 21), 'text':'( Thermo Electron Corporation ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(48, 0), 'end':(48, 4), 'text':'After confirming efficient amplification ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(48, 5), 'end':(48, 11), 'text':'equal volumes of PCR products were mixed'}, {'start':(48, 12), 'end':(48, 25), 'text':'so as to be represented in a roughly equimolar ratio in the library .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(49, 0), 'end':(49, 15), 'text':'In parallel , the reconstruction-dilution samples and control DNAs were also amplified with unique 4nt-tag-Fw primers'}, {'start':(49, 16), 'end':(49, 22), 'text':'and added to the PCR mix .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(50, 0), 'end':(50, 8), 'text':'For each library , pooled PCR products were purified'}, {'start':(50, 9), 'end':(50, 15), 'text':'( E.Z.N.A. PCR purification kit ) ,'}]}, {'start':(50, 16), 'end':(50, 32), 'text':'digested with 100 U of DpnII ( New England Biolabs ) for 1 h 30 min ,'}]}, {'start':(50, 33), 'end':(50, 59), 'text':'dephosphorylated using 4 U of SAP ( United States Biochemical ) for 1 h at 37 degreesC and heat inactivated for 15 min at 80 degreesC ,'}]}, {'start':(50, 60), 'end':(50, 77), 'text':'followed by purification ( E.Z.N.A. MicroElute PCR purification kit ) and resuspension in 15 mul sterile water .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(51, 0), 'end':(51, 20), 'text':'10 mul of the purified fragments were ligated to the Illumina Gex Adapter 1 ( annealed Adapter1a and Adapter1b sequences )'}, {'start':(51, 21), 'end':(51, 26), 'text':'using the Adapter ligation conditions .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(52, 0), 'end':(52, 9), 'text':'The ligation reaction was electrophoresed in a 3 % Tris-acetate-EDTA'}, {'start':(52, 10), 'end':(52, 28), 'text':'( TAE ) agarose gel and a slice of the expected size ( 137 bp ) was excised ,'}]}, {'start':(52, 29), 'end':(52, 35), 'text':'purified ( E.Z.N.A. gel purification kit )'}]}, {'start':(52, 36), 'end':(52, 43), 'text':'and resuspended in 25 mul sterile water .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(53, 0), 'end':(53, 12), 'text':'Each library was then enriched by a final amplification ( Gex PCR )'}, {'start':(53, 13), 'end':(53, 20), 'text':'using 1.5 mul of purified ligated products .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(54, 0), 'end':(54, 9), 'text':'The 3 libraries were prepared independently to avoid cross contamination'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(54, 10), 'end':(54, 15), 'text':'and were quantified using a fluorometer'}, {'start':(54, 16), 'end':(54, 18), 'text':'( Qubit )'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(54, 19), 'end':(54, 25), 'text':'before being validated by direct sequencing ,'}, {'start':(54, 26), 'end':(54, 35), 'text':'Pyrosequencing ( Biotage ) and Bioanalyzer ( Agilent ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(55, 0), 'end':(55, 18), 'text':'Massively parallel sequencing of the libraries was performed on 3 different channels of an Illumina GAII sequencer by ServiceXS'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(55, 19), 'end':(55, 27), 'text':'( Leiden , The Netherlands ) for 36 cycles'}, {'start':(55, 28), 'end':(55, 35), 'text':'using the Gex-DpnII sequencing primer ( ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(56, 0), 'end':(56, 8), 'text':'Estimation of mutation levels from Illumina GAII sequencing data'}, {'label':'enablement', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(57, 0), 'end':(57, 13), 'text':'To estimate the levels of each single nucleotide mutation at the FGFR3 K650 codon'}, {'start':(57, 14), 'end':(57, 27), 'text':'( corresponding to cycles 23-25 of the Illumina sequencing scheme [ ] ) ,'}]}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(57, 28), 'end':(57, 32), 'text':'we used a Bayesian approach'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(57, 33), 'end':(57, 47), 'text':'to fit a model to the observed counts at each nucleotide in the sequencing data'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(57, 48), 'end':(57, 53), 'text':'that allows for bias in frequencies'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(57, 54), 'end':(57, 59), 'text':'derived from sequencing error and noise'}, {'start':(57, 60), 'end':(57, 68), 'text':'introduced by the rounds of PCR and digestion .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(58, 0), 'end':(58, 5), 'text':'The model is similar to that'}, {'start':(58, 6), 'end':(58, 10), 'text':'used previously for Pyrosequencing ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(58, 11), 'end':(58, 17), 'text':'but allows for a different error structure'}, {'start':(58, 18), 'end':(58, 24), 'text':'arising from the GAII Illumina technology .'}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(59, 0), 'end':(59, 2), 'text':'We discarded reads'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(59, 3), 'end':(59, 29), 'text':'where the minimum Phred quality score for any of the four bases of the tag ( cycles 1-4 ) , or three bases of the K650 codon'}, {'start':(59, 30), 'end':(59, 34), 'text':'( cycles 23-25 ) ,'}]}, {'start':(59, 35), 'end':(59, 38), 'text':'was under 10 .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(60, 0), 'end':(60, 14), 'text':'We also eliminated reads with apparent frameshift errors or mutations outside the BpiI restriction site'}, {'start':(60, 15), 'end':(60, 25), 'text':'( i.e. in the invariant 16 bp primer sequence ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(61, 0), 'end':(61, 14), 'text':'Let z i be the log 10 frequency of mutation i in the sample .'}, {'start':(62, 0), 'end':(62, 16), 'text':'Our prior for z i is normal ( -8 , 2 ) for all non-wild-type species .'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(63, 0), 'end':(63, 10), 'text':'After adding the spike at concentration s j in experiment j'}, {'start':(63, 11), 'end':(63, 16), 'text':'( s 0 = 0 ,'}]}, {'label':'evaluation', 'direction':'RightToLeft', 'children':[{'start':(63, 17), 'end':(63, 22), 'text':'s 1 = 10 -5 ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(63, 23), 'end':(63, 28), 'text':'s 2 = 10 -4 )'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(63, 29), 'end':(63, 46), 'text':'the normalized frequencies of the non-wild-type mutations are given by fij = 10zi+ Ii = spikesjsj+ sumi10zi ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(63, 47), 'end':(63, 52), 'text':'where I is an indicator function'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(63, 53), 'end':(63, 59), 'text':'that takes the value 0 or 1'}, {'start':(63, 60), 'end':(63, 78), 'text':'depending on whether the mutation in question is the same as the HCH1-spike ( 1948A > C ) .'}]}]}]}]}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(64, 0), 'end':(64, 3), 'text':'We allow each experiment'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(64, 4), 'end':(64, 16), 'text':'( defined by the level of spike and the lane of the machine'}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(64, 17), 'end':(64, 23), 'text':'on which sequencing was carried out )'}, {'start':(64, 24), 'end':(64, 34), 'text':'to have separate bias and signal to noise ratio parameters .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(65, 0), 'end':(65, 3), 'text':'Specifically , we assume'}, {'start':(65, 4), 'end':(65, 31), 'text':'that the counts for the mutations in the sequencing data are multinomial with frequency vector xj = Dirichlet ( Bjf1j+ w1j , Bjf2j+ w2j , ... ) ,'}]}, {'start':(65, 32), 'end':(65, 56), 'text':'where B j represents the signal to noise ratio for experiment j and w ij represents the background for mutation i in experiment j .'}]}, {'start':(66, 0), 'end':(66, 23), 'text':'We assume a uniform ( 0,1000 ) prior for each B j and a uniform ( 0,100 ) prior for each w ij .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(67, 0), 'end':(67, 11), 'text':'Through use of the multinomial-Dirichlet model , we can integrate over x'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(67, 12), 'end':(67, 34), 'text':'to give the contribution to the total likelihood from experiment j in a given sample Lj = Gamma ( Bj+ Wj ) productiGamma'}, {'start':(67, 35), 'end':(67, 51), 'text':'( Bijfij+ wij ) xproductiGamma ( Bijfij+ wij+ Cij ) Gamma ( Bj+ Wj+ Cj ) ,'}]}, {'start':(67, 52), 'end':(67, 76), 'text':'where Wj = sumiwij , C ij is the number of reads observed with mutation i in experiment j , and Cj = sumiCij .'}]}]}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(68, 0), 'end':(68, 6), 'text':'Likelihoods are combined across samples and experiments'}, {'start':(68, 7), 'end':(68, 12), 'text':'to give a total likelihood .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(69, 0), 'end':(69, 2), 'text':'To estimate parameters'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(69, 3), 'end':(69, 4), 'text':'we used'}, {'start':(69, 5), 'end':(69, 27), 'text':'Metropolis-Hastings MCMC with sequential update of each parameter , a burn-in period of 3,000 complete parameter updates and a subsequent 10,000 samples .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(70, 0), 'end':(70, 11), 'text':'Multiple runs from different starting points were conducted to check for convergence'}, {'start':(70, 12), 'end':(70, 30), 'text':'and visual inspection was used to compare observed to expected values as a means of checking model adequacy .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(71, 0), 'end':(71, 15), 'text':'Titration data ( ) , normal wild-type control DNA and biological samples were analyzed together .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(72, 0), 'end':(72, 22), 'text':'Samples from the chain are summarized by the posterior mean value and the 95 % equal tailed probability interval ( ETPI ) .'}, {'start':(73, 0), 'end':(73, 16), 'text':'Estimated levels of all FGFR3 K650 codon substitutions for sperm and blood samples are given in .'}]}]}]}]}]}]}
173	174	{'start':(0, 0), 'end':(0, 0), 'text':'1'}
174	175	{'start':(0, 0), 'end':(0, 0), 'text':'2'}
